3 Stocks Politicians Are Buying Now

Press coverage articles continue to shed light on the trading behavior of U.S. lawmakers using Capitol Trades data, raising questions about access, influence, and the broader fairness of the system. While public trust in Congress remains strained, politicians’ investment disclosures reveal a reality that often runs counter to the financial struggles faced by ordinary Americans. Even as voters debate whether lawmakers should be banned from trading stocks altogether, the activity persists and consistently beats the market.

Recent findings underscore just how profitable these trades can be. In 2024, portfolios of Democratic lawmakers returned an impressive 31%, while Republicans trailed slightly at 26%. Some individual returns were even more striking: Representative David Rouzer recorded a 149% gain, while Nancy Pelosi, whose portfolio is tracked obsessively online, posted nearly 71%. The data confirms what many already suspect: when politicians trade, they win.

Against this backdrop, three recent trades stand out for their size and timing. On June 26, 2025, Representative Ro Khanna disclosed a $50,000 to $100,000 purchase of Mirion Technologies Inc (MIR:US), a radiation safety company benefiting from AI and energy sector tailwinds. Unlike his usual high frequency disclosures, this was a single buy and hold transaction on behalf of a child, suggesting conviction beyond routine trading. Weeks later, on July 24, Texas Republican Michael McCaul disclosed a $100,000 to $250,000 buy in Global Payments Inc (GPN:US), a fintech firm struggling under the weight of its $24 billion Worldpay acquisition. And in a more unusual move, On July 13, Florida Representative Laurel Lee disclosed $50,000 to $100,000 in TuHURA Bio Inc (HURA:US), a cancer immunotherapy developer that has shed more than 40% of its value this year.

These trades reflect both familiar trends and puzzling bets. Mirion’s alignment with the AI and energy boom makes it a logical choice, while Global Payments and TuHURA Bio highlight the risks of buying into companies facing steep declines. Yet what ties them together is not just stock performance, but the broader principle: elected officials continue to navigate markets with resources and insights unavailable to most Americans.

As critics push for reforms, the contrast is clear. Everyday investors shoulder risk without privileged access, while lawmakers’ portfolios often thrive. Capitol Trades data makes one thing certain: politicians are playing a very different game, and the scoreboard shows they are still winning.